胃癌腹膜转移的细胞学及分子生物学检测进展  

Progress of Detection Peritoneal Metastasis by Cytology and Molecular Biology in Patients with Gastric Cancer

作　　者：柳万忠[1] 韩晓鹏[2] 苏琳[2] 汤迎伟[3] 刘宏斌[2] 

机构地区：[1]兰州大学第二临床医学院 [2]兰州军区兰州总医院普外科 [3]中国人民解放军68070部队门诊部

出　　处：《现代生物医学进展》2012年第19期3744-3747,共4页Progress in Modern Biomedicine

基　　金：甘肃省自然科学基金(2009GS02430)

摘　　要：胃癌是常见的肿瘤之一,在消化道肿瘤中占首位。胃癌的临床病变缺乏特异性,大部分患者就诊时已发生了转移,多数病例就诊时已为进展期或晚期。腹膜转移是胃癌最常见的转移形式,胃癌的腹膜转移是造成患者预后差的主要原因,因此,及时地诊断腹膜转移,从而采取相应治疗,对提高患者术后生存率具有重要意义。Gastric cancer is one of common tumors, which is the first place in gastrointestinal tumors. Gastric cancer lesions lack of specificity, the majority of patients, tumors has shifted when they were treated, the majority of cases has advanced or late. Peritoneal metastasis of gastric cancer which is the most common form of transfer is the main cause of poor prognosis. Therefore, timely diagnosis of peritoneal metastasis, in taking the appropriate treatment, is important to improve the survival rate of patients.

关 键 词：胃癌 腹膜转移 诊断 

分 类 号：R735.2[医药卫生—肿瘤]